Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ford, M. P
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A user perspective on Continuous Subcutaneous Insulin Infusion (CSII) therapy

Melissa P Ford

Balliol College, Oxford, OX1 3BJ, UK, melissa.ford{at}closeconcerns.com

For this patient, clinical benefits of CSII are complemented by quality-of-life benefits. CSII allows her to eat, exercise, work, and socialise similarly to non-diabetic peers, mitigating psychosocial impacts of insulin dependence. Tailoring insulin dosage more precisely to meet insulin requirement has allowed her to pursue educational and personal goals while maintaining a healthy weight and an optimal HbA1C, without severe hypoglycaemia or diabetic ketoacidosis.

Key Words: insulin • insulin pump • adolescents • lifestyle • CSII.

The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 2, 110-111 (2004)
DOI: 10.1177/14746514040040020801


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?